scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1004801226 |
P356 | DOI | 10.2165/00024677-200605020-00002 |
P698 | PubMed publication ID | 16542048 |
P50 | author | Vered Stearns | Q87723624 |
P2860 | cites work | Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine | Q44677767 |
Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial | Q45206278 | ||
P433 | issue | 2 | |
P304 | page(s) | 83-87 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | Treatments in Endocrinology: guiding your management of endocrine disorders | Q15749555 |
P1476 | title | Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms | |
P478 | volume | 5 |
Q33940729 | Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen |
Q35511396 | Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. |
Q35671371 | Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management |
Q37847568 | HRT in difficult circumstances: are there any absolute contraindications? |
Q30408993 | Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause |
Q36858268 | Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram. |
Q48396494 | The premenstrual syndrome and fibromyalgia--similarities and common features |